Related Experiment Video
Updated: Jul 8, 2026

07:59
Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
["Targeted Therapies" in NSCLC - present and future].
1Klinische Abteilung für Allgemeine Innere Medizin, Schwerpunkt Onkologie, Universitätsklinik für Innere Medizin, Medizinische Universität Innsbruck, Innsbruck, Osterreich. georg.pall@uki.at
Wiener Medizinische Wochenschrift (1946)
|December 25, 2007
Summary
Recent advancements in targeted therapies have significantly improved Non-Small Cell Lung Cancer (NSCLC) treatment. This review updates oncologists on crucial new drugs and their impact on NSCLC care.
Area of Science:
- Oncology
- Pharmacology
Context:
- Non-Small Cell Lung Cancer (NSCLC) treatment has evolved with chemotherapy.
- Basic science research has identified key targets for cancer proliferation.
- Targeted therapies represent a new era in medical oncology.
Purpose:
- To provide an update on recent developments in targeted therapy for NSCLC.
- To assist oncologists in navigating new data and treatment guidelines.
Summary:
- Significant progress in NSCLC treatment is attributed to chemotherapy and targeted therapies.
- Identification of critical targets has led to the development of novel pharmaceutical compounds.
- The expanding landscape of targeted therapies necessitates continuous updates for clinicians.
Impact:
- Targeted therapies are altering NSCLC treatment guidelines.
- Numerous new drugs are in clinical development for NSCLC.
- This review aims to keep oncologists informed about the latest NSCLC therapeutic strategies.
Related Concept Videos
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
